Does a peptide degrade silently, with no visual change? posts 61–80

Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to adsorption. Glass vials lose less to leaching than plastics.

post #61 answers the question as asked. The question underneath it is different.

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

Coming back to post #61, because the follow-up matters more than the original answer.

Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the date tells you. Guessing on this is where errors accumulate.

Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something reconstituted at home in a different concentration with a different diluent. That caveat is not small.

Worth separating two things that post #61 runs together.

Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on whether the solution suddenly becomes unusable on a calendar date. The date is a boundary; crossing it is a risk factor not a certainty of damage.

post #65 is right about the mechanism and I think understates the practical bit.

Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but if you are unsure, the supplier can answer specifically.

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

On post #65 — agreed on the reasoning, with one qualification.

Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters because adsorptive losses are proportionally larger in dilute solutions. All of that is reasonably well supported.

Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature is usually low risk. Days to weeks raises the risk. If you are unsure, contacting the supplier is more informative than guessing.

Picking up post #68: that is the part I would want checked first.

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the formulation and is not something to test empirically. The conservative position is not to freeze.

Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something reconstituted at home in a different concentration with a different diluent. That caveat is not small.

Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the date tells you. Guessing on this is where errors accumulate.